A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: inside (292)

Carboplatin (AUC5) Retreat

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN Retreat (AUC5) Regimen • Ovary – Carboplatin (AUC5) R
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC5-Retreat.pdf

Guidance for new grant holders_May2023

Description
Guidance for new UHS* grant holders Congratulations, you’ve been awarded some research funding! Now what? What are the key
Url
/Media/Southampton-Clinical-Research/Grants/Download/Guidance-for-new-grant-holders-May2023.pdf

SoAR RLP Deputy Lead Role JD and PS

Description
Southampton Academy of Research (SoAR) Research Leaders Programme (RLP) Deputy Lead: Call for expressions of interest University of Southampton NHS Fo
Url
/Media/Southampton-Clinical-Research/Downloads/SoAR-RLP-Deputy-Lead-Role-JD-and-PS.pdf

Neratinib

Description
Chemotherapy Protocol Breast Cancer NERATINIB Regimen • Breast Cancer – Neratinib Indication • Neratinib for extended adjuvant therapy for hor
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Neratinib.pdf

Vismodegib

Description
Chemotherapy Protocol BASAL CELL CARCINOMA (BCC) VISMODEGIB Regimen  BCC - Vismodegib Indication  The patient either has; a. G
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Vismodegib.pdf

AMS FLIER summary 2022 - cohort 3 applications open

Description
Future Leaders in Innovation, Enterprise and Research (FLIER) Programme The Academy of Medical Sciences is pioneer
Url
/Media/Southampton-Clinical-Research/Grants/AMS-FLIER-summary-2022-cohort-3-applications-open.pdf

Crizotinib Ver 1

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CRIZOTINIB This protocol may require funding Regimen NSCLC - Crizotinib Indication T
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CrizotinibVer1.pdf

Aria ePrescribing v13.6 MR1.2 user training guide

Description
Aria E-Prescribing v13.6 MR1.2 User Training Guide Every effort has been made to ensure that the material in this manual was correct at the time of publication but
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/User-guides/Aria-ePrescribing-v13.6-MR1.2-user-training-guide.pdf

Bendamustine-Polatuzumab-Rituximab

Description
Chemotherapy Protocol LYMPHOMA BENDAMUSTINE-POLATUZUMAB-RITUXIMAB Regimen • Lymphoma – Bendamustine-Polatuzumab-Rituximab Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Bendamustine-Polatuzumab-Rituximab.pdf

Fulvestrant-Palbociclib

Description
Chemotherapy Protocol Breast Cancer Fulvestrant-Palbociclib Regimen • Breast Cancer – Fulvestrant-Palbociclib Indication Palbociclib with fulvestrant is recommended for use within the
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Fulvestrant-Palbociclib.pdf
281 to 290 of 1000
Previous … 27 28 29 30 31 … Next